Navigation Links
Design prototype chip makes possible a fully implantable cochlear implant
Date:2/10/2014

BOSTON (Feb. 10, 2014) Researchers from Massachusetts Eye and Ear, Harvard Medical School, and Massachusetts Institute of Technology (MIT) have designed a prototype system-on-chip (SoC) that could make possible a fully implanted cochlear implant. They will present their findings on Feb. 11at the IEEE International Solid State Circuits Conference in San Francisco.

A cochlear implant is a device that electronically stimulates the auditory nerve to restore hearing in people with profound hearing loss. Conventional cochlear implants are made up of an external unit with a microphone and sound processer to pick up and encode sound, and an internal unit that is seated in the skull and connected to an electrode array inserted into the cochlea. The external unit raises concerns in some individuals with social stigma and has limited use in the shower or during water sports.

"In addition to the cosmetic aspect of an invisible cochlear implant, a potential major functional benefit is that it can facilitate sound localization. Our system relies on a sound sensor located in the middle ear so that the user can benefit from directional cues provided by the auricle and ear canal. Conventional cochlear implants detect sound by a microphone located outside of the ear so that important directional cues are lost," said Konstantina Stankovic, M.D., Ph.D., Mass. Eye and Ear otologist who co-led the study with Anantha Chandrakasan, Ph.D., MIT head of Electrical Engineering and Computer Science. "Our long-term goal is to develop a fully implantable cochlear implant. To facilitate that development, we have developed the SoC and tested it in ears of human cadavers."

In addition, the SoC was designed to require lower power sound processing and auditory nerve stimulation to enable operation from an implantable battery that is wirelessly recharged once daily.

This project was a collaboration between the following researchers at MIT, Harvard Medical
'/>"/>

Contact: Mary Leach
Mary_Leach@meei.harvard.e
617-573-4170
Massachusetts Eye and Ear Infirmary
Source:Eurekalert

Page: 1 2

Related biology news :

1. Designer proteins provide new information about the bodys signal processes
2. New, designer fiber may help address fiber intolerance and ease IBS symptoms
3. Hoyos Labs Receives Envisioneering Innovation & Design Award at the 2014 ShowStoppers at the Consumer Electronics Show
4. Scientists uncover image of muscular dystrophy defect & design targeted drug candidates
5. IU-designed probe opens new path for drug development against leading STD
6. KAIST developed the biotemplated design of piezoelectric energy harvesting device
7. New bale unroller design deemed effective
8. Designer piercings: New membrane pores with DNA nanotechnology
9. The secret math of plants: UCLA biologists uncover rules that govern leaf design
10. Molecular biology: Designer of protein factories exposed
11. NJIT to host public reception for Rebuild by Design project proposals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... 2, 2015 At its 2015 ACMG Annual ... , the American College of Medical Genetics and ... to its Board.  Members of the ACMG Board of ... forming and advancing its policies and programs. ACMG is ... "It,s an eventful time in medical genetics and ...
(Date:3/31/2015)...  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ("Elephant ... Defined Network Architecture (ET Software DNA® 2.0) platforms and ... $20.4 million for the year ended December 31, 2014 ... year ended December 31, 2013. At ... its multi-year transition away from its legacy landline business ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... Since Edison,s first bulb, heat has been a mostly undesirable ... light into heat at the point of need, on the ... The method created by the Rice labs of Michael Wong, ... American Chemical Society journal ACS Nano makes use ...
... Panama provides an unprecedented level of detail regarding the ... to the forest canopy. Yves Basset, scientific coordinator of ... Institute, led an international team on Project IBISCA-Panama to ... hectare forest hosts a total of around 25,000 arthropod ...
... discovered a "two-faced" group of cells at work in ... or promote tumor growth. These cells are a subset ... in healthy individuals In this previously unknown Treg ... shown to differentiate between cancer-protecting and cancer-promoting properties. ...
Cached Biology News:Rice uses light to remotely trigger biochemical reactions 2Rice uses light to remotely trigger biochemical reactions 3Rice uses light to remotely trigger biochemical reactions 4More bang for bugs 2'Two-faced' cells discovered in colon cancer 2
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - BioAmber Inc. ... sustainable chemicals, today announced that it has commenced an underwritten ... expects to grant the underwriters a 30-day option to ... shares of common stock offered in the public offering. ... can be no assurance as to whether or when ...
(Date:4/30/2015)... Cambridge, MA & Budapest, Hungary (PRWEB) April 30, ... the only web-based electronic lab notebook with integrated ... leader in providing chemistry software solutions and consulting ... that led to the development of Labguru’s newest ... a set of deep domain features for biologists, ...
(Date:4/30/2015)... 30, 2015 - Continued ... Company   Shire (LSE: SHP, NASDAQ: ... months to March 31, 2015. Financial ... +9% +13% Total revenues $1,488 million +11% +15% Non ... operating income from continuing operations $475 million +55% Non ...
(Date:4/30/2015)... 30, 2015 SureClinical, a leader in ... Morris has joined SureClinical’s executive team as Chief Financial ... and technology executive with over 25 years in leadership ... , Ms. Morris joins SureClinical from Marrone Bio ... was CFO of MBI from its founding in 2006 ...
Breaking Biology Technology:BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3Labguru Integrates ChemAxon's Marvin JS, to Enhance Functionality for Chemists 2Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 2Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 3Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 4Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 5Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 6Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 7Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 8Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 9Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 10Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 11Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 12Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 13Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 14Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 15Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 16Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 17Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 18Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 19Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 20Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 21Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 22Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 23Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 24Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 25Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 26Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 27Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 28Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 29Julie I. Morris Joins SureClinical as Chief Financial Officer 2
... Free access to 'Best Practices for Long-term ... R. Rajagopal's highly successful November 2007 position ... Option', is being offered. It emphasizes the ... as it nears commercialization as a viable ...
... Relocation to California, MELBOURNE, Australia, July 10 ... Dr. Devron Averett as Chief Scientific,Advisor to the ... will work closely with the,company,s executive management team, ... scientific leadership and guidance. He has held global,leadership ...
... Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) announced that the ... passed by the U.S. House of,Representatives on June 24, ... would,continue the 2007 reimbursement methodology for therapeutic,radioimmunotherapies for an ... 2008. In December, Congress froze reimbursement rates at the ...
Cached Biology Technology:Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 2Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 3Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 4Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist 2Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 2Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 3Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 4
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
...
Homo sapiens MEP50 protein, mRNA...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Biology Products: